Rodney A Jue

Title: Rodney A Jue: Innovator in Monoclonal Antibody Technologies

Introduction

Rodney A Jue is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of methods for improving monoclonal antibodies. With a total of 2 patents, his work has had a substantial impact on the industry.

Latest Patents

Rodney A Jue's latest patents include innovative methods for the reduction of heterogeneity of monoclonal antibodies. One method involves incubating heterogeneous antibodies at low pH for a sufficient duration to convert them into substantially homogeneous forms. Another method utilizes ascites fluid to achieve the same result, while a third method employs carboxypeptidase. These homogeneous antibodies can then be purified in high yield. Additionally, he has developed a method for the separation of anti-metal chelate antibodies from non-specific proteins. This method involves applying a preparation containing the anti-metal chelate antibodies to an oxo acid derivatized solid support and eluting with a buffer that selectively separates the antibodies from non-specific proteins.

Career Highlights

Throughout his career, Rodney has worked with prominent companies such as Hybritech Incorporated and Eli Lilly and Company. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in antibody technology.

Collaborations

Rodney has collaborated with esteemed colleagues, including James P McDonough and Thomas C Furman. These partnerships have fostered an environment of innovation and have led to the development of significant advancements in the field.

Conclusion

Rodney A Jue's contributions to monoclonal antibody technologies exemplify his dedication to innovation in biotechnology. His patents reflect a commitment to improving the efficacy and purity of antibodies, which are crucial for various medical applications.